Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LIPO-Liposome -- Ignore unavailable to you. Want to Upgrade?

To: Donald Gravenor who wrote (854)	9/27/1999 5:07:00 AM
From: Daniel Levy	Read Replies (1) \| Respond to of 900

It's hard to predict what the future is with this stock. Something that I find very strange about the FDA panel's rejection was the desire of several very large pharm. companies to set up clinical trials with Evacet. Somehow, I don't think that these other companies would just stupidly throw money around for no reason. I'd predict they saw significant potential value in the drug. Now, another possibility is that they also wanted to work with the Liposome administrative people to see if a good fit could be found for a takeover. If that's the case, and they liked what they saw, we could see a significant rebound in the next few months (amount is anyone's guess). That's my 2 cents. What do others think?